CMP Pharma specializes in liquid formulations of branded medications to better serve patients who may be unable to swallow or have difficulty swallowing traditional formulations.
The FDA has recently issued stricter guidance about the use of crushed/compounded products, recommending in most instances that drugs not be crushed/compounded if FDA-approved alternatives, such as the branded oral liquids offered by CMP Pharma exist.
Atorvaliq is the first and only FDA-approved oral liquid suspension of atorvastatin calcium. To view Indications, Important Safety Information, and full Prescribing Information, please visit atorvaliq.com
Tadliq® the first and only FDA-approved oral liquid suspension of tadalafil. To view Indications, Important Safety Information, and full Prescribing Information, please visit tadliq.com
FDA-approved oral suspension of spironolactone. To view Indications, Important Safety Information, and full Prescribing Information, please visit carospir.com
Norliqva is the first FDA-approved liquid solution of amlodipine. To view Indications, Important Safety Information, and full Prescribing Information, please visit norliqva.com
